Fidelity Investments’s Neuraxis NRXS Stock Holding History

Fidelity Investments’s Portfolio NRXS Stock Details NRXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$73	Buy	+10	New	+$74	﹤0.01%	5411

Other funds holding NRXS

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCC

Money Concepts Capital Palm Beach Gardens, Florida $2.16B AUM 28.67% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Panoramic Capital Larkspur, California $232M AUM 255.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Fidelity Investments's NRXS Position: Q2 2026 in Review

Fidelity Investments opened a new position in Neuraxis (NRXS) in Q2 2026: 10 shares worth $73. The stake represents ﹤0.01% of the portfolio and ranks #5411 among its holdings.

32 funds tracked by Wall St. Rank hold NRXS as of Q2 2026.

Fidelity Investments held 10 shares of Neuraxis worth $73 as of Q2 2026.
Neuraxis was a new Fidelity Investments position in Q2 2026.
Neuraxis made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5411 holding.
32 funds tracked by Wall St. Rank held Neuraxis as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.